Cargando…

Cross-reactive antibody immunity against SARS-CoV-2 in children and adults

Detalles Bibliográficos
Autores principales:	Fraley, Elizabeth, LeMaster, Cas, Banerjee, Dithi, Khanal, Santosh, Selvarangan, Rangaraj, Bradley, Todd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165340/ https://www.ncbi.nlm.nih.gov/pubmed/34059791 http://dx.doi.org/10.1038/s41423-021-00700-0

Ejemplares similares

Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals
por: Fraley, Elizabeth, et al.
Publicado: (2021)

Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine
por: Bradley, Todd, et al.
Publicado: (2021)

Cross-reactive antibodies elicited to conserved epitopes on SARS-CoV-2 spike protein after infection and vaccination
por: Geanes, Eric S., et al.
Publicado: (2022)

Effects of Prior Infection with SARS-CoV-2 on B Cell Receptor Repertoire Response during Vaccination
por: Fraley, Elizabeth R., et al.
Publicado: (2022)

1595. Comparative In Vitro Activity of Imipenem–Relebactam Against Drug-Resistant Gram-Negative Isolates from Pediatric Patients
por: Banerjee, Dithi, et al.
Publicado: (2019)

634. Head-to Head Comparison of the Performance of BIOFIRE(®) SPOTFIRE(®) Respiratory/Sore throat Panel, Cepheid Xpert(®) Xpress SARS-CoV-2/Flu/RSV and Cobas(®) SARS-CoV-2 & Influenza A/B Assay for Detection of Respiratory Viruses
por: Banerjee, Dithi, et al.
Publicado: (2023)

High-resolution epigenome analysis in nasal samples derived from children with respiratory viral infections reveals striking changes upon SARS-CoV-2 infection
por: Winkley, Konner, et al.
Publicado: (2021)

Comparison of diagnostic performance of five molecular assays for detection of SARS-CoV-2
por: Kanwar, Neena, et al.
Publicado: (2021)

2085. Evaluation of Panther Fusion Flu A/B/RSV, AdV/hMPV/RV and Paraflu Assays for the Detection of Respiratory Viruses in Children
por: Hassan, Ferdaus, et al.
Publicado: (2018)

Autoantibodies against Angiotensin-converting enzyme 2 and immune molecules are associated with COVID-19 disease severity
por: Bradley, Todd, et al.
Publicado: (2023)

Immune cell residency in the nasal mucosa may partially explain respiratory disease severity across the age range
por: Winkley, Konner, et al.
Publicado: (2021)

184. Inducible Clindamycin Resistance Testing on Pediatric Streptococcus pneumoniae Isolates
por: Olarte, Liset, et al.
Publicado: (2021)

2185. Group A Streptococcus (GAS) Detection by PCR in Children with Viral Acute Respiratory Illness and Healthy Children
por: Banerjee, Dithi, et al.
Publicado: (2019)

Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies
por: Choy, Kay Weng
Publicado: (2021)

647. Comparative Analysis of Two Sample -to - Answer Nucleic Acid Amplification Assays for the Detection of Respiratory Viral Pathogens from Pediatric Respiratory Specimens
por: Sasidharan, Anjana, et al.
Publicado: (2023)

Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies – Authors' reply
por: Iversen, Kasper, et al.
Publicado: (2021)

1156. Pneumococcal Colonization in Children with Persistent Asthma and without Asthma
por: Olarte, Liset, et al.
Publicado: (2021)

The cellular and immunological dynamics of early and transitional human milk
por: LeMaster, Cas, et al.
Publicado: (2023)

Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants
por: Pallett, Scott J C, et al.
Publicado: (2022)

Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids()
por: Varona Pérez, J., et al.
Publicado: (2020)

SARS-CoV-2 serological cross-reactivity with autoantibodies
por: Choy, Kay Weng
Publicado: (2021)

AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC
por: Wall, Emma C, et al.
Publicado: (2021)

Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351)
por: Moyo-Gwete, Thandeka, et al.
Publicado: (2021)

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
por: Zang, Jinkai, et al.
Publicado: (2020)

No crossreactivity of anti-SARS-CoV-2 spike protein antibodies with Syncytin-1
por: Prasad, Mukul, et al.
Publicado: (2021)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
por: Lin, Qingqing, et al.
Publicado: (2020)

SARS-CoV-2 serological cross-reactivity with autoantibodies – Authors' reply
por: Teng, Jialin, et al.
Publicado: (2021)

A SARS-CoV-2 antibody retains potent neutralization against Omicron by targeting conserved RBM residues
por: Yi, Chunyan, et al.
Publicado: (2022)

Kinetics and seroprevalence of SARS-CoV-2 antibodies in children
por: Roarty, Cathal, et al.
Publicado: (2021)

The presence of SARS-CoV2 antibodies in MS patients
por: Wallach, Asya I., et al.
Publicado: (2021)

Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
por: Zheng, Ming, et al.
Publicado: (2020)

Humoral and cellular response to the COVID-19 vaccine in immunocompromised children
por: Morgans, Heather A., et al.
Publicado: (2022)

Antibody response to SARS-CoV-2 in people living with HIV
por: Yamamoto, Shinya, et al.
Publicado: (2021)

Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients
por: Del Zompo, Fabio, et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Nazemipour, Maryam, et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Ghafari, Mahan, et al.
Publicado: (2021)

Prevalence of SARS-Cov-2 Antibodies in Emergency Medicine Healthcare Workers
por: Wang, Ralph C., et al.
Publicado: (2021)

Immunoassays for anti-SARS-CoV-2 antibodies: recent insights
por: Van Elslande, Jan, et al.
Publicado: (2021)

A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD
por: Liu, Shuo, et al.
Publicado: (2022)

VH-CH1 switch region-inserting multispecific antibody designs and their efficacy against SARS-CoV-2 in vitro and in vivo
por: Wu, Lili, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rmc22rn3r1rr1oghrbuuh321ji